Quertle: Honored as a Top 50 AI Blog

Feedspot named Quertle’s blog – yes, the very site you are reading now – as one of the top 50 blogs for artificial intelligence (AI). You may note the lovely badge we now proudly display on the right! […]

2017-03-28T16:10:42+00:00 March 12th, 2017|Artificial Intelligence, News|

Insight From Biomedical Literature is Now In Sight

The importance of the biomedical literature to the pharmaceutical industry cannot be overstated. Understanding the literature is a cornerstone for discovery, publi- cation planning, competitive intelligence, identification of adverse events, compliance, and more. Despite being so essential for the industry, the methods for discovering critical information from the literature largely remain entrenched in 1950s technology. Even newer approaches, such as semantics [...]

2017-03-28T15:56:50+00:00 December 14th, 2016|News, Press Releases|

Vicki Burnett – a Woman to Watch

Dr. Vicki Burnett, Quertle co-founder, has been honored as a "Woman to Watch" by Nevada Business magazine. Her vision about Big Data, Artificial Intelligence, and the Biomedical literature are getting the recognition it deserves.  Of course, here at Quertle, we have always known she was worth watching. Congratulations to Vicki.

2016-10-16T16:07:29+00:00 October 4th, 2016|News|

Quertle releases Qinsight – a biomedical literature discovery product built on its BioAI artificial intelligence platform

HENDERSON, Nev. – Henderson, Nevada-based Quertle LLC, developer of the first artificial intelligence (AI) biomedical big data platform (BioAI™), has released Qinsight™. The product uses BioAI’s neural networks and other AI methods, along with predictive visual analytics, to enable high-efficiency discovery and insight from biomedical literature. […]

2017-03-23T16:37:01+00:00 September 26th, 2016|News|

Quertle releases BioAI – the first biomedical big data and artificial intelligence platform for drug discovery

HENDERSON, Nev. – Quertle LLC, has developed the first artificial intelligence and visual analytics big data (BioAI™) platform for biomedical drug discovery. This platform combines machine learning, neural networks, and other AI methods to improve discovery and insight. […]

2017-03-23T16:37:01+00:00 September 8th, 2016|News|